{"transactions":[{"id":691886,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-08-11T01:37:03.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 11,500 (638 post-split) RSUs, vesting on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 11,500 (638 post-split) RSUs, vesting on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":638},"source":{"system":"sec-edgar","filing":"0001193125-26-343077","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343077/ownership.xml","form_type":"4"}},{"id":691885,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Common Stock","published_at":"2026-08-11T01:37:03.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":638,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":638,"source":{"system":"sec-edgar","filing":"0001193125-26-343077","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343077/ownership.xml","form_type":"4"}},{"id":1071384,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Restricted Stock Unit","published_at":"2025-08-08T20:35:41.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":11500,"derivative":{"underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0000950170-25-105938","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025105938/ownership.xml","form_type":"4"}},{"id":1084033,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Restricted Stock Unit","published_at":"2025-07-21T20:38:27.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":false,"shares":3,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 8,550 (11 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 8,550 (11 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025."}],"balance_after":8,"derivative":{"underlying":"Common Stock","underlying_shares":11},"source":{"system":"sec-edgar","filing":"0000950170-25-097272","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097272/ownership.xml","form_type":"4"}},{"id":1084032,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Common Stock","published_at":"2025-07-21T20:38:27.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":true,"shares":3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":3,"source":{"system":"sec-edgar","filing":"0000950170-25-097272","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097272/ownership.xml","form_type":"4"}},{"id":1228494,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Restricted Stock Unit","published_at":"2025-03-04T21:32:32.000Z","date":"2025-03-04","kind":"exercise","planned":false,"acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 7, 2022, the reporting person was granted 4,750 (3 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 7, 2022, the reporting person was granted 4,750 (3 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 4, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0000950170-25-032183","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025032183/ownership.xml","form_type":"4"}},{"id":1228493,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Restricted Stock Unit","published_at":"2025-03-04T21:32:32.000Z","date":"2025-03-02","kind":"exercise","planned":false,"acquired":false,"shares":2,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 3, 2023, the reporting person was granted 11,000 (7 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 3, 2023, the reporting person was granted 11,000 (7 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024."}],"balance_after":2,"derivative":{"underlying":"Common Stock","underlying_shares":2},"source":{"system":"sec-edgar","filing":"0000950170-25-032183","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025032183/ownership.xml","form_type":"4"}},{"id":1228492,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Common Stock","published_at":"2025-03-04T21:32:32.000Z","date":"2025-03-04","kind":"exercise","planned":false,"acquired":true,"shares":1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":18,"source":{"system":"sec-edgar","filing":"0000950170-25-032183","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025032183/ownership.xml","form_type":"4"}},{"id":1228491,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Common Stock","published_at":"2025-03-04T21:32:32.000Z","date":"2025-03-02","kind":"exercise","planned":false,"acquired":true,"shares":2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":17,"source":{"system":"sec-edgar","filing":"0000950170-25-032183","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025032183/ownership.xml","form_type":"4"}},{"id":1436924,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Restricted Stock Unit","published_at":"2024-08-09T20:30:57.000Z","date":"2024-08-08","kind":"exercise","planned":false,"acquired":false,"shares":158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 13,889 (315 post-split) RSUs, vesting in two approximately equal annual installments beginning on August 8, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 13,889 (315 post-split) RSUs, vesting in two approximately equal annual installments beginning on August 8, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":158},"source":{"system":"sec-edgar","filing":"0000950170-24-094813","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024094813/ownership.xml","form_type":"4"}},{"id":1436923,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Common Stock","published_at":"2024-08-09T20:30:57.000Z","date":"2024-08-08","kind":"exercise","planned":false,"acquired":true,"shares":158,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":576,"source":{"system":"sec-edgar","filing":"0000950170-24-094813","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024094813/ownership.xml","form_type":"4"}},{"id":1451203,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Restricted Stock Unit","published_at":"2024-07-19T20:37:25.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":8550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in three approximately equal annual installments beginning on July 17, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in three approximately equal annual installments beginning on July 17, 2025."}],"balance_after":8550,"derivative":{"underlying":"Common Stock","underlying_shares":8550},"source":{"system":"sec-edgar","filing":"0000950170-24-084955","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024084955/ownership.xml","form_type":"4"}},{"id":1596319,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Restricted Stock Unit","published_at":"2024-03-05T21:13:50.000Z","date":"2024-03-04","kind":"exercise","planned":false,"acquired":false,"shares":1584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 7, 2022, the reporting person was granted 4,750 RSUs, vesting in three approximately equal annual installments beginning on March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 7, 2022, the reporting person was granted 4,750 RSUs, vesting in three approximately equal annual installments beginning on March 4, 2023."}],"balance_after":1583,"derivative":{"underlying":"Common Stock","underlying_shares":1584},"source":{"system":"sec-edgar","filing":"0000950170-24-025921","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024025921/ownership.xml","form_type":"4"}},{"id":1596318,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Restricted Stock Unit","published_at":"2024-03-05T21:13:50.000Z","date":"2024-03-02","kind":"exercise","planned":false,"acquired":false,"shares":3667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 3, 2023, the reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 3, 2023, the reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024."}],"balance_after":7333,"derivative":{"underlying":"Common Stock","underlying_shares":3667},"source":{"system":"sec-edgar","filing":"0000950170-24-025921","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024025921/ownership.xml","form_type":"4"}},{"id":1596317,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Common Stock","published_at":"2024-03-05T21:13:50.000Z","date":"2024-03-04","kind":"exercise","planned":false,"acquired":true,"shares":1584,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":18411,"source":{"system":"sec-edgar","filing":"0000950170-24-025921","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024025921/ownership.xml","form_type":"4"}},{"id":1596316,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Common Stock","published_at":"2024-03-05T21:13:50.000Z","date":"2024-03-02","kind":"exercise","planned":false,"acquired":true,"shares":3667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":16827,"source":{"system":"sec-edgar","filing":"0000950170-24-025921","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024025921/ownership.xml","form_type":"4"}},{"id":1666507,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Restricted Stock Unit","published_at":"2024-01-30T23:05:56.000Z","date":"2024-01-29","kind":"exercise","planned":false,"acquired":false,"shares":792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 29, 2021, the reporting person was granted 2,375 RSUs, vesting in three approximately equal annual installments beginning on January 29, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 29, 2021, the reporting person was granted 2,375 RSUs, vesting in three approximately equal annual installments beginning on January 29, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":792},"source":{"system":"sec-edgar","filing":"0000950170-24-009005","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024009005/ownership.xml","form_type":"4"}},{"id":1666506,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Common Stock","published_at":"2024-01-30T23:05:56.000Z","date":"2024-01-29","kind":"exercise","planned":false,"acquired":true,"shares":792,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":13160,"source":{"system":"sec-edgar","filing":"0000950170-24-009005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024009005/ownership.xml","form_type":"4"}},{"id":1810868,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Restricted Stock Unit","published_at":"2023-08-10T12:47:11.000Z","date":"2023-08-08","kind":"exercise","planned":false,"acquired":false,"shares":6945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 13,889 RSUs, vesting in two approximately equal installments beginning on August 8, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 13,889 RSUs, vesting in two approximately equal installments beginning on August 8, 2023."}],"balance_after":6944,"derivative":{"underlying":"Common Stock","underlying_shares":6945},"source":{"system":"sec-edgar","filing":"0001209191-23-045267","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123045267/doc4.xml","form_type":"4"}},{"id":1810867,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Common Stock","published_at":"2023-08-10T12:47:11.000Z","date":"2023-08-08","kind":"exercise","planned":false,"acquired":true,"shares":6945,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":12368,"source":{"system":"sec-edgar","filing":"0001209191-23-045267","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123045267/doc4.xml","form_type":"4"}},{"id":1965879,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Restricted Stock Unit","published_at":"2023-03-07T21:41:12.000Z","date":"2023-03-04","kind":"exercise","acquired":false,"shares":1583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 7, 2022, the reporting person was granted 4,750 RSUs, vesting in three approximately equal annual installments beginning on March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On June 7, 2022, the reporting person was granted 4,750 RSUs, vesting in three approximately equal annual installments beginning on March 4, 2023."}],"balance_after":3167,"derivative":{"underlying":"Common Stock","underlying_shares":1583},"source":{"system":"sec-edgar","filing":"0001209191-23-016783","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123016783/doc4.xml","form_type":"4"}},{"id":1965878,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Restricted Stock Unit","published_at":"2023-03-07T21:41:12.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in three approximately equal annual installments beginning on March 2, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in three approximately equal annual installments beginning on March 2, 2024."}],"balance_after":11000,"derivative":{"underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-23-016783","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123016783/doc4.xml","form_type":"4"}},{"id":1965877,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-07T21:41:12.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in three approximately equal annual installments beginning on March 2, 2024."}],"balance_after":11000,"derivative":{"exercise_price":2.15,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-23-016783","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123016783/doc4.xml","form_type":"4"}},{"id":1965876,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25017,"kind":"person","name":"Taylor Daphne","position":1,"cik":"0001393549","reported_name":"Taylor Daphne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO"}}],"security":"Common Stock","published_at":"2023-03-07T21:41:12.000Z","date":"2023-03-04","kind":"exercise","acquired":true,"shares":1583,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":5423,"source":{"system":"sec-edgar","filing":"0001209191-23-016783","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123016783/doc4.xml","form_type":"4"}}]}